Brian K Shoichet Selected Research

Brian K Shoichet Research Topics

Disease

6	Neoplasms (Cancer) 01/2020 - 08/2012
4	Pain (Aches) 10/2022 - 01/2016
4	COVID-19 12/2021 - 01/2020
3	Infections 01/2020 - 03/2008
2	Drug-Related Side Effects and Adverse Reactions 03/2021 - 06/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2011 - 05/2010
1	Neuralgia (Stump Neuralgia) 12/2021
1	Hypersensitivity (Allergy) 12/2021
1	Virus Diseases (Viral Diseases) 03/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Substance-Related Disorders (Drug Abuse) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2016
1	Respiratory Insufficiency (Respiratory Failure) 01/2016
1	Catalepsy 01/2016
1	Type 2 Diabetes Mellitus (MODY) 10/2015
1	Abdominal Pain (Pain, Abdominal) 06/2012
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 08/2011
1	Schizophrenia (Dementia Praecox) 02/2011
1	Chagas Disease (American Trypanosomiasis) 07/2010
1	Whooping Cough (Pertussis) 07/2003
1	Anthrax 07/2003

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 12/2021 - 06/2012
3	Antiviral Agents (Antivirals)IBA 03/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 03/2020 - 01/2020
3	EnzymesIBA 01/2020 - 06/2012
2	LigandsIBA 10/2022 - 12/2021
2	VaccinesIBA 03/2020 - 01/2020
2	Colloids (Colloid)IBA 01/2019 - 08/2012
2	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 01/2016
2	Clozapine (Clozaril)FDA LinkGeneric 01/2016 - 02/2011
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2020
1	Eukaryotic Initiation Factor-4EIBA 01/2020
1	Excipients (Suspending Agents)IBA 01/2020
1	Hallucinogens (Psychedelics)IBA 01/2020
1	Lysergic Acid Diethylamide (LSD)IBA 01/2020
1	Psilocybin (Psilocibin)IBA 01/2020
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2019
1	Fulvestrant (Faslodex)FDA Link 01/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	AcidsIBA 01/2019
1	Transferrin (beta 2 Transferrin)IBA 01/2019
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2018
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	berbineIBA 10/2016
1	Serotonin 5-HT2 Receptor AgonistsIBA 01/2016
1	HhAntag691IBA 01/2016
1	Opioid Analgesics (Opioids)IBA 01/2016
1	Analgesics (Analgesic Drugs)IBA 01/2016
1	Phencyclidine (Angel Dust)IBA 01/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2016
1	Opioid Receptors (Opioid Receptor)IBA 01/2016
1	ArrestinIBA 01/2016
1	nuciferineIBA 01/2016
1	Morphine (MS Contin)FDA LinkGeneric 01/2016
1	AlkaloidsIBA 01/2016
1	Metformin (Glucophage)FDA LinkGeneric 10/2015
1	Molecular Probes (Molecular Probe)IBA 07/2013
1	Cefotaxime (Kendrick)FDA LinkGeneric 10/2012
1	AlbuminsIBA 08/2012
1	Coloring Agents (Dyes)IBA 08/2012
1	Evans Blue (Blue, Evans)FDA Link 08/2012
1	Chlorotrianisene FDA Link 06/2012
1	Cyclooxygenase 1IBA 06/2012
1	Protein Isoforms (Isoforms)IBA 08/2011
1	Prion ProteinsIBA 08/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2011
1	cruzipainIBA 07/2010
1	Sulfhydryl Compounds (Thiols)IBA 07/2010
1	Peptide Hydrolases (Proteases)FDA Link 07/2010
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 05/2010
1	Biological ProductsIBA 03/2008
1	PrionsIBA 03/2008
1	edema factorIBA 07/2003
1	AntitoxinsIBA 07/2003
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 07/2003

Therapy/Procedure

2	Therapeutics 03/2021 - 03/2020
1	Analgesia 01/2016